These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 29262503)

  • 61. Interactions between acute lymphoblastic leukemia and bone marrow stromal cells influence response to therapy.
    Tesfai Y; Ford J; Carter KW; Firth MJ; O'Leary RA; Gottardo NG; Cole C; Kees UR
    Leuk Res; 2012 Mar; 36(3):299-306. PubMed ID: 21889797
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance protein.
    Stam RW; van den Heuvel-Eibrink MM; den Boer ML; Ebus ME; Janka-Schaub GE; Allen JD; Pieters R
    Leukemia; 2004 Jan; 18(1):78-83. PubMed ID: 14574327
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Bone marrow stromal cells modulate mouse ENT1 activity and protect leukemia cells from cytarabine induced apoptosis.
    Macanas-Pirard P; Leisewitz A; Broekhuizen R; Cautivo K; Barriga FM; Leisewitz F; Gidi V; Riquelme E; Montecinos VP; Swett P; Besa P; Ramirez P; Ocqueteau M; Kalergis AM; Holt M; Rettig M; DiPersio JF; Nervi B
    PLoS One; 2012; 7(5):e37203. PubMed ID: 22629369
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A bioluminescent microbial biosensor for in vitro pretreatment assessment of cytarabine efficacy in leukemia.
    Alloush HM; Anderson E; Martin AD; Ruddock MW; Angell JE; Hill PJ; Mehta P; Smith MA; Smith JG; Salisbury VC
    Clin Chem; 2010 Dec; 56(12):1862-70. PubMed ID: 20921267
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The combination regimen of idarubicin and taxotere is effective against human drug-resistant leukemic cell lines.
    Majlessipour F; Avramis IA; Kwock R; Weinberg KI; Avrami VI
    Anticancer Res; 2002; 22(3):1361-8. PubMed ID: 12168812
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Astaxanthin decreases the growth-inhibitory dose of cytarabine and inflammatory response in the acute lymphoblastic leukemia cell line NALM-6.
    Rastgar A; Sayadi M; Anani-Sarab G; Sajjadi SM
    Mol Biol Rep; 2022 Jul; 49(7):6415-6422. PubMed ID: 35441937
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Determination of drug synergism between the tyrosine kinase inhibitors NSC 680410 (adaphostin) and/or STI571 (imatinib mesylate, Gleevec) with cytotoxic drugs against human leukemia cell lines.
    Avramis IA; Laug WE; Sausville EA; Avramis VI
    Cancer Chemother Pharmacol; 2003 Oct; 52(4):307-18. PubMed ID: 12827297
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Effect of bone marrow stromal cells on the apoptotic sensitivity of HL-60 and HL-60/VCR cells].
    Liang R; Huang GS; Wang Z; Chen XQ; Bai QX; Zhang WP; Wang JH; Wang WQ; Guo Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Apr; 13(2):286-92. PubMed ID: 15854294
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Bone marrow stroma damage induced by chemotherapy for acute lymphoblastic leukemia in children.
    Corazza F; Hermans C; Ferster A; Fondu P; Demulder A; Sariban E
    Pediatr Res; 2004 Jan; 55(1):152-8. PubMed ID: 14561785
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis.
    Ray S; Bullock G; Nuñez G; Tang C; Ibrado AM; Huang Y; Bhalla K
    Cell Growth Differ; 1996 Dec; 7(12):1617-23. PubMed ID: 8959329
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Effects of RNA interference inhibiting SDF-1 expression in bone marrow stromal cells on the proliferation and apoptosis of co-cultured Jurkat cells].
    Yang WB; Kong PY; Chang C; Wei L; Zeng DF; Peng XG; Shi ZZ; Liu H; Liu L; Chen XH; Wang QY
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jul; 26(7):421-4. PubMed ID: 16251026
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Resistance of human leukemic cell lines to 1-beta-D-arabinofuranosylcytosine: characterization of an experimental model.
    Gariboldi MB; Ravizza R; Marras E; Perletti G; De Simone A; Piccinini F; Monti E
    Int J Oncol; 2001 Jun; 18(6):1245-9. PubMed ID: 11351258
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Effects of inhibiting SDF-1 expression by RNA interference on adhesion and drug sensitivity of Jurkat cells co-cultured with bone marrow stromal cells].
    Yang WB; Kong PY; Chang C; Wei L; Zeng DF; Peng XG; Shi ZZ; Liu H; Liu L; Chen XH; Wang QY
    Zhonghua Xue Ye Xue Za Zhi; 2005 Aug; 26(8):458-60. PubMed ID: 16383234
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Role of c-Myc in mesenchymal stromal cell-mediated drug resistance in acute leukemia cells].
    Xia B; Guo Q; Zhao WP; Guo SQ; Tian C; Zhang YZ
    Zhonghua Yi Xue Za Zhi; 2013 Jun; 93(22):1746-9. PubMed ID: 24124686
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The study of resistant mechanisms and reversal in an imatinib resistant Ph+ acute lymphoblastic leukemia cell line.
    Xing H; Yang X; Liu T; Lin J; Chen X; Gong Y
    Leuk Res; 2012 Apr; 36(4):509-13. PubMed ID: 22285507
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The MitoNEET Ligand NL-1 Mediates Antileukemic Activity in Drug-Resistant B-Cell Acute Lymphoblastic Leukemia.
    Geldenhuys WJ; Nair RR; Piktel D; Martin KH; Gibson LF
    J Pharmacol Exp Ther; 2019 Jul; 370(1):25-34. PubMed ID: 31010844
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Overexpression of heme oxygenase-1 in microenvironment mediates vincristine resistance of B-cell acute lymphoblastic leukemia by promoting vascular endothelial growth factor secretion.
    Yu K; Wang J; Lu T; Ma D; Wei D; Guo Y; Cheng B; Wang W; Fang Q
    J Cell Biochem; 2019 Oct; 120(10):17791-17810. PubMed ID: 31264739
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cytosine-arabinoside stimulates the capability of human marrow stromal cells to support normal hematopoiesis.
    Li H; Koh KR; Toramoto T; Nakamae H; Yamane T; Ohta K; Hino M
    Osaka City Med J; 2010 Dec; 56(2):11-20. PubMed ID: 21466125
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [The Mechanism of Artesunate Combined with Cytarabine and/or Daunorubicin on the Apoptosis of MV4-11 MLL-rearranged Acute Myeloid Leukemia Cell Line].
    Li JY; Xiong X; Wang DW; Zhang XY; Huang C; Zou LL; Zheng CF; Chen X; Tu CQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1724-1729. PubMed ID: 36476895
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Timed sequential therapy of acute leukemia with flavopiridol: in vitro model for a phase I clinical trial.
    Karp JE; Ross DD; Yang W; Tidwell ML; Wei Y; Greer J; Mann DL; Nakanishi T; Wright JJ; Colevas AD
    Clin Cancer Res; 2003 Jan; 9(1):307-15. PubMed ID: 12538483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.